Product NDC: | 0603-5803 |
Proprietary Name: | Sulfasalazine |
Non Proprietary Name: | sulfasalazine |
Active Ingredient(s): | 500 mg/1 & nbsp; sulfasalazine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, DELAYED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0603-5803 |
Labeler Name: | Qualitest Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075339 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020111 |
Package NDC: | 0603-5803-21 |
Package Description: | 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0603-5803-21) |
NDC Code | 0603-5803-21 |
Proprietary Name | Sulfasalazine |
Package Description | 100 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (0603-5803-21) |
Product NDC | 0603-5803 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sulfasalazine |
Dosage Form Name | TABLET, DELAYED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20020111 |
Marketing Category Name | ANDA |
Labeler Name | Qualitest Pharmaceuticals |
Substance Name | SULFASALAZINE |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |